March 13, 2014

‘Missing link’ may spur new brain disorder drugs

Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

By Bill Snyder

August 15, 2013

Center for Quality Aging forges community bonds

The Vanderbilt Center for Quality Aging is taking the “bench to bedside” concept of translational research out into the community, forming partnerships with assisted living facilities to examine how evidence can be put into action to improve the care of elders.

By Vanderbilt Health News

August 1, 2013

Cognitive complaints, Alzheimer’s risk studied

A study of cognitive complaints in older adults showed that memory concerns from both the patient and an informant was most predictive of converting to Alzheimer’s disease or dementia within three years.

By Vanderbilt Health News

January 14, 2013

AstraZeneca, VU collaborate to develop new treatments for major brain disorders

AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

By Bill Snyder

October 11, 2012

Amish aid search for Alzheimer’s genes

An analysis of Amish populations revealed novel risk genes for late-onset Alzheimer disease.

By Leigh MacMillan

January 19, 2012

Dr. William Petrie on Alzheimer’s disease

By Vanderbilt Health News